| Molecular formula | C37H51N9O10S |
| Molecular weight | 813.9 g/mol |
| Registered trials | 0 |
| PubChem CID | 9811102 |
What Semax Is
Semax is a synthetic peptide compound with the molecular formula C37H51N9O10S and a molecular weight of about 813.9 g/mol (PubChem CID 9811102). It has no approved drug label from the FDA and is not sold as an approved medication in the United States. Research materials describing semax are intended for laboratory or investigational use, not for human treatment.
Regulatory Status
Semax is classified as an unapproved research compound. No FDA label, indication, or dosing information exists for this substance, and it has not been reviewed or cleared for medical use in humans.
Clinical Trial Footprint
As of the most recent data pull, there are no registered clinical trials for semax in the reviewed database. This means there is currently no publicly tracked clinical trial activity to summarize for phase, status, or study population.
FAQ
No. Semax has no FDA-approved label, and it is classified as an unapproved research compound. It is not sold as an approved prescription or over-the-counter medication in the United States.
Semax is a synthetic peptide with the molecular formula C37H51N9O10S and a molecular weight of approximately 813.9 g/mol. Its chemical identity is catalogued under PubChem CID 9811102.
Based on the current data, there are no registered clinical trials for semax. This means no phase, enrollment, or outcome data is publicly available to review.
Semax does not have an approved medical use, and no label exists describing indications, mechanism, or safety information. Any use outside of approved research settings falls outside current regulatory oversight.
Chemical identity information for semax comes from public chemical databases such as PubChem. Clinical trial and safety reporting data are drawn from public registries, which currently show no listed trials for this compound.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem ClinicalTrials.gov
Updated 2026-08-03